Sagimet Biosciences Inc (SGMT) Directors and Executive Officers

Officers & Directors

Richard Rogers
Director

Elizabeth Grammer, Esq.
Director

Joseph Oriti
Interim Principal Financial Officer (Interim Principal Financial and Accounting Officer)

George Kemble, PhD
Executive Chairman of the Board

Beth Seidenberg, MD
Director

David Happel
President, Chief Executive Officer, and Director

Merdad Parsey, PhD
Director ,

Sagimet Biosciences inc currently has 16 employees.

News about Sagimet Biosciences inc Key Personnel

Sagimet Biosciences Looks to Secure Financial Health with New CFO Appointment

SAN MATEO, Calif., May 06, 2024 - Sagimet Biosciences Inc. (Sagimet, Nasdaq: SGMT), a clinical-stage biopharmaceutical company specializing in developing groundbreaking fatty acid synthase (FASN) inhibitors to address dysfunctional metabolic and fibrotic pathways, has recently announced the appointment of Thierry Chauche as Chief Financial Officer (CFO). The move comes as Sagimet seeks to strengthen its financial foundations and drive future growth and innovation.
Thierry Chauche brings with him a wealth of experience and expertise in finance. With a successful track record spanning over two decades, Chauche has held several key leadership positions within the healthcare and biotech industry. His st...